Olaplex (NASDAQ:OLPX – Free Report) had its price target boosted by Telsey Advisory Group from $2.00 to $2.06 in a research note released on Friday,Benzinga reports. Telsey Advisory Group currently has a market perform rating on the stock.
A number of other analysts also recently commented on the company. Northland Securities downgraded Olaplex from a “strong-buy” rating to a “hold” rating in a research report on Thursday. Zacks Research raised Olaplex from a “strong sell” rating to a “hold” rating in a research report on Thursday, February 19th. Weiss Ratings restated a “sell (d)” rating on shares of Olaplex in a research note on Thursday, January 22nd. Morgan Stanley set a $1.40 target price on Olaplex in a research report on Tuesday, March 10th. Finally, Barclays set a $1.75 target price on Olaplex in a research note on Friday, January 16th. Two investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Olaplex presently has a consensus rating of “Hold” and a consensus target price of $1.89.
View Our Latest Analysis on OLPX
Olaplex Stock Up 0.5%
Olaplex (NASDAQ:OLPX – Get Free Report) last posted its quarterly earnings data on Thursday, March 5th. The company reported $0.01 EPS for the quarter, meeting the consensus estimate of $0.01. Olaplex had a negative net margin of 2.19% and a positive return on equity of 1.07%. The firm had revenue of $105.12 million during the quarter, compared to analyst estimates of $104.21 million. During the same quarter last year, the business posted $0.01 EPS. The company’s revenue for the quarter was up 4.4% on a year-over-year basis. Research analysts predict that Olaplex will post 0.1 EPS for the current fiscal year.
Insider Buying and Selling
In other Olaplex news, insider Trisha L. Fox sold 25,421 shares of the firm’s stock in a transaction on Thursday, March 12th. The stock was sold at an average price of $1.26, for a total value of $32,030.46. Following the completion of the sale, the insider directly owned 1,080,363 shares of the company’s stock, valued at $1,361,257.38. This trade represents a 2.30% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, General Counsel John C. Duffy sold 34,962 shares of the business’s stock in a transaction on Thursday, March 12th. The shares were sold at an average price of $1.26, for a total value of $44,052.12. Following the completion of the sale, the general counsel owned 982,855 shares in the company, valued at approximately $1,238,397.30. The trade was a 3.43% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 215,442 shares of company stock valued at $271,457. 4.30% of the stock is owned by company insiders.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently made changes to their positions in the company. Portolan Capital Management LLC increased its holdings in Olaplex by 132.6% in the 3rd quarter. Portolan Capital Management LLC now owns 3,635,124 shares of the company’s stock worth $4,762,000 after acquiring an additional 2,072,383 shares during the last quarter. Russell Investments Group Ltd. lifted its holdings in Olaplex by 284.7% during the fourth quarter. Russell Investments Group Ltd. now owns 1,909,836 shares of the company’s stock valued at $2,559,000 after purchasing an additional 1,413,423 shares during the last quarter. Balyasny Asset Management L.P. lifted its holdings in Olaplex by 1,314.1% during the second quarter. Balyasny Asset Management L.P. now owns 1,508,013 shares of the company’s stock valued at $2,111,000 after purchasing an additional 1,401,369 shares during the last quarter. Archon Capital Management LLC boosted its position in Olaplex by 40.4% during the fourth quarter. Archon Capital Management LLC now owns 4,466,876 shares of the company’s stock worth $5,986,000 after purchasing an additional 1,284,557 shares during the period. Finally, Bridgeway Capital Management LLC boosted its position in Olaplex by 56.2% during the second quarter. Bridgeway Capital Management LLC now owns 2,629,139 shares of the company’s stock worth $3,681,000 after purchasing an additional 946,265 shares during the period. Institutional investors own 87.37% of the company’s stock.
Key Olaplex News
Here are the key news stories impacting Olaplex this week:
- Positive Sentiment: Henkel agreed to acquire Olaplex for $2.06 per share (≈$1.4 billion), a ~55% premium to the pre-announcement close; the deal is being pitched as enabling greater investment and distribution for the brand. OLAPLEX to be Acquired by Henkel for $1.4 Billion
- Positive Sentiment: Heavy bullish activity and strong market reaction: premarket headlines and commentary noted a large surge after the announcement, and unusual options activity (large buy of calls) signaled speculative and takeover-arbitrage positioning. Wall Street Breakfast Podcast: Henkel Adds Shine With Olaplex
- Neutral Sentiment: Small analyst adjustments: Telsey Advisory Group raised its price target marginally to $2.06 and kept a “market perform” rating — a modest validation of the deal price but not a strong new bullish signal. Benzinga
- Negative Sentiment: Multiple shareholder-law firms have launched investigations into whether Olaplex shareholders received a fair price or whether there were breaches of fiduciary duty in connection with the sale — this raises litigation risk and could complicate closing/timing. M&A Class Action Firm Announces Investigation Ademi Firm Investigates Fair Price
- Negative Sentiment: Critical analysis and a downgrade: commentary pieces flagged negative implications of the sale for certain stakeholders, and Northland downgraded the stock from “strong-buy” to “hold” — both could reduce enthusiasm among some investors. Henkel Buys Olaplex – Implications Are Negative Zacks (Northland downgrade)
Olaplex Company Profile
Olaplex, Inc (NASDAQ: OLPX) is a specialty haircare company known for its patented bond-building technology designed to repair and strengthen hair from within. The company’s core offerings encompass a range of professional salon treatments and at-home maintenance products that target chemical damage, breakage and split ends. Olaplex formulations are built around a proprietary active ingredient that works at the molecular level to rebuild disulfide bonds broken during bleaching, coloring and heat styling processes.
Founded in 2014 and headquartered in Irvine, California, Olaplex initially gained traction among high-end salons before expanding into broader retail channels.
Further Reading
Receive News & Ratings for Olaplex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olaplex and related companies with MarketBeat.com's FREE daily email newsletter.
